These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11304)

  • 1. Actions of amfonelic acid and other non-amphetamine stimulants on the dopamine neuron.
    Shore PA
    J Pharm Pharmacol; 1976 Nov; 28(11):855-7. PubMed ID: 11304
    [No Abstract]   [Full Text] [Related]  

  • 2. Cocaine and phencyclidine. Heterogenous dopaminergic interactions with tetrabenazine.
    Bagchi SP
    Neuropharmacology; 1985 Jan; 24(1):37-41. PubMed ID: 3982601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergent reserpine effects on amfonelic acid and amphetamine stimulation of synaptosomal dopamine formation from phenylalanine.
    Bagchi SP; Smith TM; Bagchi P
    Biochem Pharmacol; 1980 Nov; 29(21):2957-62. PubMed ID: 6109534
    [No Abstract]   [Full Text] [Related]  

  • 4. Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.
    Matsuda LA; Hanson GR; Gibb JW
    J Pharmacol Exp Ther; 1989 Dec; 251(3):901-8. PubMed ID: 2600821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylphenidate-like stimulants in vitro release [3H]tyramines but not [14C]dopamine.
    Dyck LE
    Eur J Pharmacol; 1981 Jan; 69(3):371-4. PubMed ID: 6111462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic properties and mechanism of action of amfonelic acid.
    Aceto MD; Botton I; Martin R; Levitt M; Bentley HC; Speight PT
    Eur J Pharmacol; 1970; 10(3):344-54. PubMed ID: 4393073
    [No Abstract]   [Full Text] [Related]  

  • 7. A comparison of CNS stimulants with phencyclidine on dopamine release using in vivo voltammetry.
    Howard-Butcher S; Blaha CD; Lane RF
    Brain Res Bull; 1984 Oct; 13(4):497-501. PubMed ID: 6151866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different effects of amphetamine and amfonelic acid on peripheral and central catecholamine metabolism.
    Speciale SG; Karoum F; Wyatt RJ
    Eur J Pharmacol; 1980 Apr; 62(4):297-307. PubMed ID: 6102920
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies on the long-term depletion of striatal dopamine in iprindole-treated rats by amphetamine.
    Fuller RW; Hemrick-Luecke SK
    Neuropharmacology; 1982 May; 21(5):433-8. PubMed ID: 7110533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of (+)-amphetamine, methylphenidate, and amfonelic aid on catecholamine synthesis in selected regions of the rat brain.
    Lawson-Wendling KL; Demarest KT; Moore KE
    J Pharm Pharmacol; 1981 Dec; 33(12):803-4. PubMed ID: 6121859
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of amphetamine and amfonelic acid on the disposition of striatal newly synthesized dopamine.
    Miller HH; Shore PA
    Eur J Pharmacol; 1982 Feb; 78(1):33-44. PubMed ID: 6122585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroadaptations involved in amphetamine and cocaine addiction.
    White FJ; Kalivas PW
    Drug Alcohol Depend; 1998; 51(1-2):141-53. PubMed ID: 9716936
    [No Abstract]   [Full Text] [Related]  

  • 13. The central stimulatory action of inhibitors of the dopamine uptake.
    Ross SB
    Life Sci; 1979 Jan; 24(2):159-67. PubMed ID: 33315
    [No Abstract]   [Full Text] [Related]  

  • 14. Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression.
    Calipari ES; Ferris MJ; Salahpour A; Caron MG; Jones SR
    Nat Commun; 2013; 4():2720. PubMed ID: 24193139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of apomorphine, neuroleptics and stimulants with alpha-methyl-m-tyramine, a false dopaminergic transmitter.
    Dorris RL; Shore PA
    Biochem Pharmacol; 1974 Feb; 23(4):867-72. PubMed ID: 4150986
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of dopamine receptors by bupropion: comparison with antidepressants and CNS stimulants.
    Vassout A; Bruinink A; Krauss J; Waldmeier P; Bischoff S
    J Recept Res; 1993; 13(1-4):341-54. PubMed ID: 8095555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amfonelic acid: similarity to other dopamine agonists.
    Schechter MD
    Pharmacol Biochem Behav; 1987 Feb; 26(2):413-6. PubMed ID: 3575360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
    Steranka LR
    Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of classical and atypical antipsychotic drugs in combination with a non-amphetamine stimulant on rat brain dopamine metabolism.
    McMillen BA
    J Pharm Pharmacol; 1981 Aug; 33(8):544-6. PubMed ID: 6115934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.